Tuesday, September 18, 2018
 
 
Company News: Page (1) of 1 - 10/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
New CDC Study Shows Many Healthcare Providers Reuse Syringes, Needles, and Single-Dose Vials for Multiple Patients
 
(October 17, 2017)
New CDC Study Shows Many Healthcare Providers Reuse Syringes, Needles, and Single-Dose Vials for Multiple Patients

A new study conducted by the Centers for Disease Control and Prevention (CDC) investigating the prevalence of reusing syringes, needles, and vials for multiple patients was recently published and brings to light some very important points about keeping patients safe. The study, published in the American Journal of Infection Control, surveyed both physicians and nurses to determine how often these practices are used.

Amazingly, over 12% of doctors and 3% of nurses responded stating that reuse of syringes for more than a single patient occurs where they work. Furthermore, 5% of doctors said that it occurred, "usually or always". In addition, the study showed that 25% of the physicians surveyed utilized single-dose vials for multiple patients, 29% used IV solution from a bag or bottle for more than one patient, and 43% reentered a multidose vial with the same syringe for an additional dose for the same patient.

It is clear that more work needs to be done to educate the medical community of the risks associated with these practices. For example, drawing multiple doses from a preservative-free single-dose vial can result in contaminated doses being administered to patients. Likewise, reentering a vial twice with the same syringe can easily contaminate the contents of the vial with blood-blood infections, such as Hepatitis B, Hepatitis C, and HIV.



Edge Pharmacy Services is a strong supporter of the One Needle, One Syringe, One Time Campaign. Edge works with hospitals, surgery centers, and private physician offices to help bring providers into compliance with CDC guidelines, as well as USP 797 regulations, for drawing and administering injections. To that end, Edge provides customers with premixed, unit-dose medications which alleviate these issues, making health care safer for both the patient, as well as the providers.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14719323.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Brain Ischemia Market Analysis 2018-2023 | Increased Prevalence Rate with Topmost Players ThromboGenics, Vernalis, Neurotec Pharma, Covidien and Others - Asserts MRFR
  • IV Infusion Pump Accessories Market is poised to register a CAGR of 4.5% by 2025 – Persistence Market Research
  • Effie Chow Qigong Healing System Available On Mediterranean Celebrity Cruise Line Says Sharon Kleyne & Rose Hong
  • The Methuselah Foundation Successfully Closes its Boutique Venture Fund, the Methuselah Fund, Focused on Companies That Can Extend the Healthy Human Lifespan
  • Report on CPH by Research Dynamics: Investor Day update

    Cancer
  • Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society
  • Astellas Promotes Geoff Towle to Vice President of Oncology Marketing at Astellas US
  • Chardan Advises NovellusDX in Cross-Border Biotech Merger
  • Eroll Grow Tech (Seedo) Merges Its Activities With GRCR Partners; Cannabics Pharmaceuticals to Own 13.6% in the Merged Company
  • Chemotherapy-Induced Nausea & Vomiting (CINV) Treatment - Worldwide Markets to 2026: A $3.62 Billion Opportunity
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines